Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCIENCE GROUP PLC Share Issue/Capital Change 2022

Nov 3, 2022

7903_sha_2022-11-03_928258cc-3a03-45f7-a5a9-6cf54b6f48dd.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2676F

Science Group PLC

03 November 2022

3 November 2022

Science Group plc

(the "Company" or "Science Group")

Treasury shares issued

Science Group plc (AIM:SAG) announces that on 3 November 2022 the Company issued 13,333 treasury shares at an average price of 1 pence per share in settlement of the exercise of share options. 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 45,436,823.  Science Group holds 749,051 shares in treasury and a further 104,400 shares are held by the Frontier Smart Technologies Employee Benefit Trust.  The total number of voting rights in the Company following this announcement is therefore 45,332,423.

The figure of 45,332,423 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

- Ends -

For further information:

Science Group plc
Sarah Cole, Company Secretary Tel: +44 (0) 1223 875 200
www.sciencegroup.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)
Nick Adams, Alex Price, Richard Short Tel: +44 (0) 20 7710 7600
Liberum Capital Limited (Joint Broker)
Neil Patel, Cameron Duncan Tel: +44 (0) 20 3100 2000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TRSEALFDESDAFFA